XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.3%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (14190)	7/20/2000 9:53:36 PM
From: aknahow	Read Replies (1) of 17367

Yes, I think you are right or some announcement is planned and both partners are interested in providing some sort of surprise. Do I believe this last part? To some extent not saying anything must have been the result of a decision. BAX could have said we are still waiting for peer reviewed article or have decided not to file a BLA, or we will be filing for approval in Europe, or have decided not to pursue the Meningococcemia indication, or we will be going into clinic for an undisclosed indication before the end of the year. etc. etc. In other words I believe neither Neuprex nor XOMA were mentioned because Baxter/XOMA are going to say something soon. Might be something negative, might be positive. I lean to the positive, if a surprise is intended, since no company plans a negative surprise. But nothing now, was a choice. If I keep repeating this even I might believe it. <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next